{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:21:26Z","timestamp":1648747286573},"reference-count":10,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.medcli.2008.06.027","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T08:36:41Z","timestamp":1243499801000},"page":"779-782","source":"Crossref","is-referenced-by-count":0,"title":["Consulta de riesgo oncol\u00f3gico. Selecci\u00f3n de grupos de riesgo y resultados"],"prefix":"10.1016","volume":"132","author":[{"given":"Maite","family":"Cusid\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Colom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"F\u00e1bregas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2008.06.027_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: collaborative reanalysis of indivudual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without disease","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2008.06.027_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case seies unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.medcli.2008.06.027_bib3","unstructured":"Departament de Salut. Generalitat de Catalunya. Oncoguia del consell i assessorament gen\u00e8tics en el c\u00e0ncer hereditari. Disponible en: http:\/\/www.aatrm.net\/html\/es\/dir420\/doc11310.html"},{"key":"10.1016\/j.medcli.2008.06.027_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","article-title":"Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects","volume":"22","author":"D\u00edez","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.medcli.2008.06.027_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1157\/13100569","article-title":"C\u00e1ncer de mama y ovario hereditario: prevenci\u00f3n primaria y secundaria en mujeres portadoras de mutaci\u00f3n en los genes BRCA1 y BRCA2","volume":"128","author":"Llort","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2008.06.027_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2008.06.027_bib7","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2008.06.027_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2006.08.004","article-title":"Hereditary Ovarian Cancer Clinical Study Group. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","volume":"104","author":"Beiner","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.medcli.2008.06.027_bib9","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2008.06.027_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577530800198X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577530800198X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T09:22:22Z","timestamp":1545211342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577530800198X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":10,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S002577530800198X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2008.06.027","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}